Multimídia | Portal Regional da BVS

Recursos encontrados: 304

WHO's Science in 5 on COVID-19: vaccines, variants & herd immunity

Data: 26/02/2021

As new variants emerge people are wondering if they should wait until a more efficacious vaccine is available or if they should go ahead and get vaccinated now? Answering your questions on COVID-19 vaccines and variants in this episode of Science in 5 is WHO's Dr Soumya Swaminathan.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, Mutação/genética, Betacoronavirus/genética, Infecções por Coronavirus/genética, Pneumonia Viral/genética, COVID-19, Covax

Safety of COVID-19 vaccines: what we need to know

Data: 19/02/2021

As the world rolls out COVID-19 vaccines, many people are asking what to expect – in particular, are these vaccines safe? The answer is yes, but here’s a bit more information you may find useful.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, COVID-19

WHO’s Science in 5 on COVID-19: vaccine dosage

Data: 19/02/2021

How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured?
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/administração & dosagem, Relação Dose-Resposta Imunológica, COVID-19

Follow the journey of a vaccine

Data: 04/02/2021

From clinic trials and emergency use listing to production, transportation, storage and final administration by local health workers – follow the journey of a vaccine.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/normas, COVID-19

Here is how Pfizer/BioNTech COVID-19 vaccine should be used

Data: 03/02/2021

The Pfizer/BioNTech COVID-19 vaccine is the first vaccine to receive WHO validation for emergency use. Here is how it should be used.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/provisão & distribuição, COVID-19, Pfizer, BioNTech

The road to a COVID-19 vaccine

Data: 01/02/2021

Developing a vaccine is a long road full of checkpoints. Each phase designed to make sure it is both effective and safe. But with the whole world struggling to contain a pandemic, and unprecedented amounts of funding available, the road to finding the COVID-19 vaccine looks more like this.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Programas de Imunização/organização & administração, Vacinas Virais/provisão & distribuição, COVID-19

COVID-19​ live Q&A about vaccines, diagnostics & therapeutics safety. Ask WHO​ of 20 January 2021

Data: 20/01/2021

#AskWHO​ series: This was the live discussion of 20 January 2021 about the COVID-19 vaccines, diagnostics and therapeutics safety assessment and approvals for use.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, Terapias em Estudo, Monitoramento Epidemiológico, COVID-19

COVID-19​ vaccines live Q&A with Dra Kate L. O´Brien and Dr Alejandro Cravioto. Ask WHO​ of 7 Jan. 2021

Data: 07/01/2021

AskWHO​ series: This was the live discussion about the COVID-19 pandemic of 7 January 2021 with Dr Alejandro Cravioto, Chair of the WHO Strategic Advisory Experts Group on Immunization and Dr Katherine O’Brien, Head of WHO Immunization, Vaccines and Biologicals department answer questions about COVID-19 vaccines from the general public.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Protocolo de Ensaio Clínico, Vacinas Virais/imunologia, Relação Dose-Resposta Imunológica, Vacinas Virais/efeitos adversos, Vacinas Virais/provisão & distribuição, Acesso a Medicamentos Essenciais e Tecnologias em Saúde, COVID-19

Getting vaccines, medicines and tests ready for emergency use

Data: 21/12/2020

Making vaccines, tests and medicines available can take a long time, even when there’s a health emergency like COVID -19. To ensure rapid access for all, the World Health Organization has developed the Emergency Use Listing - EUL - and this video explains how EUL works.
Ver detalhes

Infecções por Coronavirus/prevenção & controle, Pneumonia Viral/prevenção & controle, Pandemias/prevenção & controle, Acesso a Medicamentos Essenciais e Tecnologias em Saúde, Comunicação em Saúde, COVID-19

How COVID-19 vaccines are able to be developed so fast?

Data: 07/12/2020

WHO Chief Scientis, Dr Soumya Swaminathan, explains why COVID-19 vaccines are able to be developed so fast.
Ver detalhes

Betacoronavirus/imunologia, Infecções por Coronavirus/imunologia, Pneumonia Viral/imunologia, Pandemias/prevenção & controle, Comunicação em Saúde, Vacinas Virais/imunologia, COVID-19